Interconnection circadian rhythm of blood pressure in overweight patients with hypertension and osteoarthritis
DOI:
https://doi.org/10.11603/1811-2471.2015.v23.i2-3.5274Abstract
Summary. An important factor in combination osteoarthritis and hypertension is that the first treatment of the disease in many cases leads to the progression of the other. And even in the presence of overweight hormones and cytokines, which creates adipose tissue, interacting at the level of neuronal systems, causing hyperactivation of sympathetic activity, increase in blood pressure. Daily monitoring of blood pressure – the only non-invasive method of examination, which allows you to: obtain information on levels of and fluctuations in blood pressure throughout the day.
Thus, in patients with combined flow of arterial hypertension and osteoarthritis observed a significant increase in daily average blood pressure, which may be due to several reasons. Based on the analysis of changes in daily monitoring of blood pressure found that when comorbid course of hypertension and osteoarthritis recorded significantly higher average daily value of systolic blood pressure and diastolic blood pressure, increasing its variability, and all changes are progressing with increasing body mass index.
Key words: hypertension, obesity, osteoarthritis, daily monitoring of blood pressure, body mass index.
References
Belovol A. N. Patofyzyolohycheskye mekhanyzmy razvytyya arteryalʹnoy hypertenzyy na fone ozhyrenyya / A. Belovol, V. Shkolʹnyk // Nauk. zh. MOZ Ukrayiny. – 2012. – № 1. – S. 142–150.
Bokarev Y. N. Sovremennye podkhody k lechenyyu pervychnoy arteryalʹnoy hypertonyy / Y. Bokarev, E. Matvyenko // Klyn. med. – 2013. – № 3. – S. 4–8.
Burʺyanov O. A. Osteoartroz: pytannya patohenezu, diahnostyka ta likuvannya / O. Burʺyanov // Zdorovʺya Ukrayiny. – 2009. – № 23 (228). – S. 30–32.
Vyzyrʹ V. A. Sutochnye rytmy arteryalʹnoho davlenyya y ykh patohenetycheskye osobennosty na raznykh stadyyakh hypertonycheskoy bolezny/ V. A. Vyzyrʹ, Y. N. Voloshyna // Suchasni medychni tekhnolohiyi. – 2011. – № 2. – S. 77–80.
Denysov L. N. Rolʹ ozhyrenyya v razvytyy osteoartroza y soput·stvuyushchykh zabolevanyy / L. Denysov, V. Nasonova. // Terapevt. arkh. – 2010. – № 10. – S. 34–37.
Kit Z. M. Korelyatyvni zvʺyazky mizh pokaznykamy oksydu azotu, arhininu, leptynu, endotelinu-1 ta osnovnymy komponentamy lipidnoho spektra krovi u khvorykh na hipertonichnu khvorobu z normalʹnoyu, nadlyshkovoyu masoyu tila ta ozhyrinnyam / Z. Kit // Lʹviv. med. chasopys. – 2009. – T. 15, № 1. – S. 56–60.
Kovaleva O. N. Abdomynalʹnoe ozhyrenye, dyslypydemyya, tsytokyny y massa myokarda levoho zheludochka pry arteryalʹnoy hypertenzyy / O. Kovaleva, D. Sorokyn, T. Ambrosova // Krovoobih ta hemostaz. – 2009. – № 1–2. – S. 48–53.
Kovalʹova O. M. Vzayemozvʺyazok pokaznykiv lipidotransportnoyi systemy i vuhlevodnoho obminu u patsiyentiv, khvorykh na arterialʹnu hipertenziyu z suputnim ozhyrinnyam / O. Kovalʹova, O. Pionova // Eksperym. i klin. med. – 2011. – № 3. – S. 61–67.
Mamedov M. N. Ratsyonalʹnyy podkhod v lechenyy arteryalʹnoy hypertonyy u bolʹnykh s vysokym serdechno-sosudystym ryskom y metabolycheskymy narushenyyamy / M. Mamedov, M. Kovryhyna, Z. Tohuzova // Kardyolohyya. – 2013. – № 2 (53). – S. 85–90.
Pionova O. M. Dodatkovi markery kardiovaskulyarnoho ryzyku u khvorykh na arterialʹnu hipertenziyu z ozhyrinnyam / O. Pionova, O. Kovalʹova // Eksperym. i klin. med. – 2012. – № 2. – S. 79–84.
Prystupa YE. N. Vzayemozvʺyazok osteoartrozu ta ozhyrinnya / YE. Prystupa, L. Prystupa, O. Opimakh // Hal. likar. visnyk. – 2010. – T. 17, № 3. – S. 178-181.
Shylov A. Patofyzyolohycheskye osobennosty arteryalʹnoy hypertonyy pry ozhyrenyy: dyahnostyka y pryntsypy lechenyya / A. Shylov, A. Avshalumov, V. Markovskyy // Lech. vrach. – 2009. – № 2. – S. 9–12.
Dumond H. Evidence for a key role of leptin in osteoarthritis / H. Dumond, N. Presle, B. Terlain // Arthritis Rheum. – 2003. – Vol. 48 (11). – P. 3118–3129.
Harle P. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis / P. Harle, G. Pongratz, C. Weidler // Ann. Rheum. Dis. –2004. – Vol. 63. – P. 809–816.
Marks R. Body mass indices in patients with disabling hip osteoarthritis / R. Marks, J.P. Allegrante // Arthritis Res. –2002. – Vol. 4. – P. 112–116.
Popa C. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis / C. Popa, M. G. Netea, T. R. Radstake // Ann. Rheum. Dis. – 2005. – Vol. 64. – P. 1195–1198.
